Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
French Endocrine Society Guidance on endocrine side effects of immunotherapy.
Castinetti F, Albarel F, Archambeaud F, Bertherat J, Bouillet B, Buffier P, Briet C, Cariou B, Caron P, Chabre O, Chanson P, Cortet C, Do Cao C, Drui D, Haissaguerre M, Hescot S, Illouz F, Kuhn E, Lahlou N, Merlen E, Raverot V, Smati S, Verges B, Borson-Chazot F. Castinetti F, et al. Among authors: hescot s. Endocr Relat Cancer. 2019 Feb;26(2):G1-G18. doi: 10.1530/ERC-18-0320. Endocr Relat Cancer. 2019. PMID: 30400055 Free PMC article.
Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors.
Vezzosi D, Do Cao C, Hescot S, Bertherat J, Haissaguerre M, Bongard V, Drui D, De La Fouchardière C, Illouz F, Borson-Chazot F, Djobo B, Berdelou A, Tabarin A, Schlumberger M, Briet C, Caron P, Leboulleux S, Libe R, Baudin E; For Comete-Cancer Network. Vezzosi D, et al. Among authors: hescot s. Horm Cancer. 2018 Feb;9(1):62-69. doi: 10.1007/s12672-017-0313-6. Epub 2017 Oct 25. Horm Cancer. 2018. PMID: 29071575 Free PMC article.
Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions.
Castinetti F, Albarel F, Archambeaud F, Bertherat J, Bouillet B, Buffier P, Briet C, Cariou B, Caron P, Chabre O, Chanson P, Cortet C, Do Cao C, Drui D, Haissaguerre M, Hescot S, Illouz F, Kuhn E, Lahlou N, Merlen E, Raverot V, Smati S, Verges B, Borson-Chazot F. Castinetti F, et al. Among authors: hescot s. Ann Endocrinol (Paris). 2018 Oct;79(5):591-595. doi: 10.1016/j.ando.2018.07.005. Epub 2018 Jul 11. Ann Endocrinol (Paris). 2018. PMID: 30056975 Review.
Expert opinions on adrenal complications in immunotherapy.
Haissaguerre M, Hescot S, Bertherat J, Chabre O. Haissaguerre M, et al. Among authors: hescot s. Ann Endocrinol (Paris). 2018 Oct;79(5):539-544. doi: 10.1016/j.ando.2018.07.002. Epub 2018 Jul 11. Ann Endocrinol (Paris). 2018. PMID: 30149891 Review.
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study.
Hescot S, Curras-Freixes M, Deutschbein T, van Berkel A, Vezzosi D, Amar L, de la Fouchardière C, Valdes N, Riccardi F, Do Cao C, Bertherat J, Goichot B, Beuschlein F, Drui D, Canu L, Niccoli P, Laboureau S, Tabarin A, Leboulleux S, Calsina B, Libé R, Faggiano A, Schlumberger M, Borson-Chazot F, Mannelli M, Gimenez-Roqueplo AP, Caron P, Timmers HJLM, Fassnacht M, Robledo M, Borget I, Baudin E; European Network for the Study of Adrenal Tumors (ENS@T). Hescot S, et al. J Clin Endocrinol Metab. 2019 Jun 1;104(6):2367-2374. doi: 10.1210/jc.2018-01968. J Clin Endocrinol Metab. 2019. PMID: 30715419 Free article.
Locally unresectable differentiated thyroid cancer: outcomes and perspectives.
Lamartina L, Godbert Y, Nascimento C, Do Cao C, Hescot S, Borget I, Al Ghuzlan A, Hartl D, Hadoux J, Pottier E, Attard M, Berdelou A, Terroir M, Baudin E, Schlumberger M, Leboulleux S; with the support of the TUTHYREF network. Lamartina L, et al. Among authors: hescot s. Endocrine. 2020 Jul;69(1):133-141. doi: 10.1007/s12020-020-02245-0. Epub 2020 Mar 8. Endocrine. 2020. PMID: 32147774
Recurrence-Free Survival Analysis in Locally Advanced Pheochromocytoma: First Appraisal.
Moog S, Castinetti F, DoCao C, Amar L, Hadoux J, Lussey-Lepoutre C, Borson-Chazot F, Vezzosi D, Drui D, Laboureau S, Raffin Sanson ML, Lamartina L, Pierre P, Batisse Ligner M, Hescot S, Al Ghuzlan A, Renaudin K, Libé R, Laroche S, Deniziaut G, Gimenez-Roqueplo AP, Jannin A, Leboulleux S, Guerin C, Faron M, Baudin E. Moog S, et al. Among authors: hescot s. J Clin Endocrinol Metab. 2021 Aug 18;106(9):2726-2737. doi: 10.1210/clinem/dgab202. J Clin Endocrinol Metab. 2021. PMID: 33782697
Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC study.
Hadoux J, Walter T, Kanaan C, Hescot S, Hautefeuille V, Perrier M, Tauveron I, Laboureau S, Do Cao C, Petorin C, Blanchet O, Faron M, Leteurtre E, Rousselet MC, Joubert Zakeyh J, Marchal A, Chatelain D, Beaulaton C, Hervieu V, Lombard-Bohas C, Ducreux M, Scoazec JY, Baudin E; Groupe d’Etude des Tumeurs Endocrines (GTE); ENDOCAN-RENATEN network. Hadoux J, et al. Among authors: hescot s. Endocr Relat Cancer. 2022 Aug 17;29(10):569-580. doi: 10.1530/ERC-22-0102. Print 2022 Oct 1. Endocr Relat Cancer. 2022. PMID: 35920609
55 results